WHO Digital Documentation of COVID-19 Certificates (DDCC)
1.0.0 - CI Build
WHO Digital Documentation of COVID-19 Certificates (DDCC)
1.0.0 - CI Build
WHO Digital Documentation of COVID-19 Certificates (DDCC), published by WHO. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/ddcc/tree/main and changes regularly. See the Directory of published versions
| Official URL: http://smart.who.int/ddcc/ConceptMap/vaccine-covid19-cvx-to-icd11 | Version: 1.0.0 | |||
| Draft as of 2023-02-15 | Computable Name: VaccineCovid19CvxToIcd11ConceptMap | |||
Copyright/Legal: TODO: provide copyright information |
||||
Vaccine - COVID-19 - CVX mapped to ICD-11
Generated Narrative: ConceptMap vaccine-covid19-cvx-to-icd11
Mapping from (not specified) to (not specified)
Group 1 Mapping from CVX codes used in this IG to http://id.who.int/icd11/mms
| Source Code | Relationship | Target Code |
| 207 (COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose) | maps to wider concept | XM3DT5 (COVID-19 Vaccine Moderna) |
| 208 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose) | maps to wider concept | XM8NQ0 (Comirnaty) |
| 210 (COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL ) | maps to wider concept | XM4YL8 (COVID-19 Vaccine AstraZeneca) |
| 211 (COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL) | maps to wider concept | XM9T65 (Novavax COVID-19 vaccine) |
| 212 (COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL) | maps to wider concept | XM6QV1 (COVID-19 Vaccine Janssen) |
| 213 (SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED) | maps to wider concept | XM68M6 (COVID-19 vaccines) |
| 217 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose) | maps to wider concept | XM8NQ0 (Comirnaty) |
| 218 (COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose) | maps to wider concept | XM8NQ0 (Comirnaty) |
| 219 (COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose) | maps to wider concept | XM8NQ0 (Comirnaty) |
| 221 (COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose) | maps to wider concept | XM3DT5 (COVID-19 Vaccine Moderna) |
| 225 (COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL) | maps to wider concept | XM3CT4 (Recombinant SARS-CoV-2 vaccine) |
| 226 (COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL) | maps to wider concept | XM3CT4 (Recombinant SARS-CoV-2 vaccine) |
| 227 (COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose) | maps to wider concept | XM3DT5 (COVID-19 Vaccine Moderna) |
| 228 (COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose) | maps to wider concept | XM3DT5 (COVID-19 Vaccine Moderna) |
| 229 (COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose) | maps to wider concept | XM3DT5 (COVID-19 Vaccine Moderna) |
| 230 (COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL) | maps to wider concept | XM3DT5 (COVID-19 Vaccine Moderna) |
| 300 (COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose) | maps to wider concept | XM8NQ0 (Comirnaty) |
| 301 (COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose) | maps to wider concept | XM8NQ0 (Comirnaty) |
| 302 (COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose) | maps to wider concept | XM8NQ0 (Comirnaty) |
| 500 (COVID-19 Non-US Vaccine, Product Unknown) | maps to wider concept | XM68M6 (COVID-19 vaccines) |
| 501 (COVID-19 IV Non-US Vaccine (QAZCOVID-IN)) | maps to wider concept | XM1NL1 (COVID-19 vaccine, inactivated virus) |
| 502 (COVID-19 IV Non-US Vaccine (COVAXIN)) | is equivalent to | XM1G90 (Covaxin) |
| 503 (COVID-19 LAV Non-US Vaccine (COVIVAC)) | is equivalent to | XM85P5 (Covi-Vac) |
| 504 (COVID-19 VVnr Non-US Vaccine (Sputnik Light)) | is equivalent to | XM5QM6 (Sputnik-Light) |
| 505 (COVID-19 VVnr Non-US Vaccine (Sputnik V)) | is equivalent to | XM5ZJ4 (Gam-Covid-Vac) |
| 506 (COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology)) | is equivalent to | XM1AG7 (Convidecia) |
| 507 (COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)) | maps to wider concept | XM5JC5 (COVID-19 vaccine, virus protein subunit) |
| 508 (COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)) | maps to wider concept | XM5JC5 (COVID-19 vaccine, virus protein subunit) |
| 509 (COVID-19 PS Non-US Vaccine (EpiVacCorona)) | is equivalent to | XM6SZ8 (EpiVacCorona) |
| 510 (COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)) | is equivalent to | XM8866 (BBIBP-CorV) |
| 511 (COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)) | is equivalent to | XM7HT3 (CoronaVac®) |
| 512 (SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)) | maps to wider concept | XM1J92 (COVID-19 vaccine, virus like particle) |
| 513 (SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)) | maps to wider concept | XM5JC5 (COVID-19 vaccine, virus protein subunit) |
| 514 (SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)) | is equivalent to | XM52P3 (ZvCov-D) |
| 515 (SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)) | is equivalent to | XM4EC8 (MVC-COV1901) |
| 516 (COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)) | is equivalent to | XM9TQ1 (KCONVAC) |
| 517 (SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)) | maps to wider concept | XM5JC5 (COVID-19 vaccine, virus protein subunit) |
| 518 (COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)) | maps to wider concept | XM1NL1 (COVID-19 vaccine, inactivated virus) |
| 519 (COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna) | is equivalent to | XM3DT5 (COVID-19 Vaccine Moderna) |
| 520 (COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech) | is equivalent to | XM8NQ0 (Comirnaty) |